Breast tumor resembling the tall cell variant of papillary thyroid carcinoma

Breast Journal

Volumn 15, Issue 5, 2009, Pages 531-535

  Chang, Sing Yun ^b   Fleiszer, David M ^a   Mesurolle, Benoît ^a   Khoury, Mona El ^a   Omeroglu, Atilla ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Breast carcinoma; Papillary carcinoma; Tan cell variant; Thyroid

Indexed keywords

CONJUGATED ESTROGEN; PROGESTERONE RECEPTOR; THYROID TRANSCRIPTION FACTOR 1;

AGED; ARTICLE; ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CYST; BREAST FIBROADENOMA; BREAST LESION; BREAST PAPILLOMA; BREAST SURGERY; BREAST TUMOR; CANCER SURGERY; CASE REPORT; DIAGNOSTIC ERROR; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; LYMPHADENECTOMY; NEEDLE BIOPSY; PARTIAL MASTECTOMY; SEGMENTAL MASTECTOMY; THYROID FUNCTION; THYROID PAPILLARY CARCINOMA;

AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA, PAPILLARY; FEMALE; FOLLOW-UP STUDIES; GENETIC VARIATION; HUMANS; MASTECTOMY, SEGMENTAL; NEOPLASM INVASIVENESS; SENTINEL LYMPH NODE BIOPSY; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 70449730113     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2009.00773.x     Document Type: Article

References (11)

1. 1. Eusebi V, Damiani S, Ellis IO, Azzopardi JG, Rosai J. Breast tumor resembling the tall cell variant of papillary thyroid carcioma: report of 5 cases. Am J Surg Pathol 2003;27:1114-1118 (Pubitemid 36909532)
2. Lester SC. Manual of Surgical Pathology, 2nd edn. Philadelphia, PA: Elsevier, 2006:240-64, 79-80, 99, 115.
3. 3. Tosi AL, Ragazzi M, Asioli S, et al. Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: report of 4 cases with evidence of malignant potential. Int J Surg Pathol 2007;15:14-19 (Pubitemid 44888024)
4. 4. Cameselle-Teijeiro J, Abdulkader I, Barreiro-Morandeira F, et al. Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: a case report. Int J Surg Pathol 2006;14:79-84. (Pubitemid 43221623)
5. 5. Gomez-Fernandez C, Jorda M, Delgado PI, Ganjei-Azar P. Thyroid transcription factor 1: a marker for lung adenocarcinoma in body cavity fluids. Cancer Cytopathol 2002;96:289-293 (Pubitemid 35221616)
6. 6. Bejarano PA, Nikiforov YE, Swenson ES, Biddinger PW. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms. Appl Immunohistochem Mol Morphol 2000;8:189-194 (Pubitemid 30677904)
7. Wick MR, Lillemoe TJ, Copiand GT, Swanson PE, Mannel JC, Kiang DT. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol 1989;20:281-297
8. 8. Nasr MR, Mukhopadhyay S, Zhang S, Katzenstein AL. Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: utility of HBMEl combined with CK19 immunostaining. Mod Pathol 2006;19:1631-1637 (Pubitemid 44789932)
9. 9. El-Rehim DMA, Pinder SE, Paish CE, et al. Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 2004;203:661-671 (Pubitemid 38714103)
10. Gatalica Z. Immunohistochemical analysis of apocrine breast lesion. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ. Pathol Res Pract 1997;193:753-758
11. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual, 6th edn. New York, NY: Springer, 2002:221-240